191 results on '"Bentow, Chelsea"'
Search Results
2. Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome
3. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets
4. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
5. The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination
6. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype
7. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis
8. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study
9. Detection of anti-dsDNA antibodies by computer-aided automated immunofluorescence analysis
10. Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
11. Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
12. Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis
13. Deciphering the Autoantibody Response to the OJ Antigenic Complex
14. Clinical Validity of Anti-Proteinase 3 Antibodies in Patients with Inflammatory Bowel Disease: A Short Meta-Analysis.
15. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey
16. PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease
17. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens
18. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis
19. Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
20. Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
21. Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus
22. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis
23. UTILITY OF PR3-ANCA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
24. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
25. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
26. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
27. Evaluation of A Novel Particle-Based Multi-Analyte Technology for the Detection of Anti-Fibrillarin Antibodies
28. Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
29. Antibodies against glycoprotein 2 and anti-neutrophil cytoplasmic antibodies targeting the serine proteinase 3 are markers of severe primary sclerosing cholangitis (PSC) and progression to cholangiocarcinoma (CCA)
30. Novel Anti–Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis
31. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis
32. Additional file 1 of Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
33. SELECTION OF THE ANTIGENIC TARGET FOR THE MEASUREMENT OF ANTI-SARS-COV-2 ANTIBODIES IN CORONAVIRUS DISEASE (COVID-19) PATIENTS
34. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies
35. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
36. Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2–Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead Immunoassays
37. Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience
38. AB0262 SERUM CALPROTECTIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS
39. AB0274 THE PREDICTIVE VALUE OF RHEUMATOID FACTOR, ANTI-CITRULLINATED PROTEIN ANTIBODIES, ANTI-CARBAMYLATED PROTEIN: ANTIBODIES AND ANTI-PEPTIDYL ARGININE DEIMINASE TYPE-3 ANTIBODIES, ALONE OR IN COMBINATION, ON RADIOGRAPHIC DAMAGE IN RHEUMATOID ARTHRITIS
40. THU0346 EVALUATION OF A NOVEL PARTICLE-BASED ASSAY FOR DETECTION OF MYOSITIS SPECIFIC ANTIBODIES
41. THU0680 ANTI-PEPTIDYL-ARGININE DEIMINASE 3 AND 4 AUTOANTIBODIES IN A COHORT OF RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE
42. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype
43. Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
44. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus
45. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
46. Mo1036 - Prevalence of Primary Biliary Cholangitis-Related Autoantibodies in Patients with Celiac Disease
47. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus
48. FRI141 - Antibodies against glycoprotein 2 and anti-neutrophil cytoplasmic antibodies targeting the serine proteinase 3 are markers of severe primary sclerosing cholangitis (PSC) and progression to cholangiocarcinoma (CCA)
49. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype
50. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.